These results imply the high efficiency of utilizing H19 regulation with DT A. The efficiency of BC-819 (DT A-H19) plasmid was earlier established against different lung cancer cell lines, including A549, NCI-H358, and NCI-H460 cells with a >90% reduction in cell growth [197]. This evidence concerns the gene H19 and lung carcinoma.